[go: up one dir, main page]

DK1173766T3 - Isoform af tenascin-C som markör for neoplasier - Google Patents

Isoform af tenascin-C som markör for neoplasier

Info

Publication number
DK1173766T3
DK1173766T3 DK00925224T DK00925224T DK1173766T3 DK 1173766 T3 DK1173766 T3 DK 1173766T3 DK 00925224 T DK00925224 T DK 00925224T DK 00925224 T DK00925224 T DK 00925224T DK 1173766 T3 DK1173766 T3 DK 1173766T3
Authority
DK
Denmark
Prior art keywords
isoform
tenascin
neoplasia
marker
ctn
Prior art date
Application number
DK00925224T
Other languages
Danish (da)
English (en)
Inventor
Luciano Zardi
Original Assignee
Philogen Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philogen Spa filed Critical Philogen Spa
Application granted granted Critical
Publication of DK1173766T3 publication Critical patent/DK1173766T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK00925224T 1999-04-20 2000-04-19 Isoform af tenascin-C som markör for neoplasier DK1173766T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999FI000094A IT1307864B1 (it) 1999-04-20 1999-04-20 Metodo diagnostico per il riconoscimento di neoplasie umane attraversola determinazione dell'isoforma ctn-c della tn-c, frammenti di
PCT/EP2000/003550 WO2000063699A1 (fr) 1999-04-20 2000-04-19 Une isoforme de la tenascine-c comme marqueur de neoplasies
EP00925224A EP1173766B1 (fr) 1999-04-20 2000-04-19 Une isoforme de la tenascine-c comme marqueur de neoplasies

Publications (1)

Publication Number Publication Date
DK1173766T3 true DK1173766T3 (da) 2005-01-31

Family

ID=11352932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925224T DK1173766T3 (da) 1999-04-20 2000-04-19 Isoform af tenascin-C som markör for neoplasier

Country Status (11)

Country Link
US (1) US7109301B1 (fr)
EP (1) EP1173766B1 (fr)
JP (1) JP4577665B2 (fr)
AT (1) ATE277352T1 (fr)
AU (1) AU779015B2 (fr)
CA (1) CA2370666C (fr)
DE (1) DE60014064T2 (fr)
DK (1) DK1173766T3 (fr)
ES (1) ES2226823T3 (fr)
IT (1) IT1307864B1 (fr)
WO (1) WO2000063699A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317108B1 (it) * 2000-12-06 2003-05-26 Philogen Srl Processo per la selezione di frammenti anticorporali anti-angiogenesi,frammenti anticorpali anti-angiogenesi cosi' ottenuti e loro uso.
US7189820B2 (en) * 2001-05-24 2007-03-13 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (APRIL)
CN1615315A (zh) * 2001-11-19 2005-05-11 应用分子发展公司 肿瘤特异性单克隆抗体
BRPI0517967B8 (pt) * 2004-11-09 2021-05-25 Philogen Spa anticorpo isolado que liga-se a tenascina-c humana
SI2757091T1 (en) 2008-04-01 2018-01-31 Biosearch Technologies, Inc. Stabilized nucleic acid black gas-fluorofor probe
MX2013001336A (es) 2010-08-13 2013-03-08 Roche Glycart Ag Anticuerpos ani-tenascina c a2 y metodos de utilizacion.
WO2017194441A1 (fr) 2016-05-11 2017-11-16 F. Hoffmann-La Roche Ag Anticorps anti-ténascine modifiés et méthodes d'utilisation
JP7285076B2 (ja) 2016-05-11 2023-06-01 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト Ｔｎｆファミリーリガンドトリマーとテネイシン結合部分とを含む抗原結合分子
GB201621806D0 (en) 2016-12-21 2017-02-01 Philogen Spa Immunocytokines with progressive activation mechanism
EP3601346A1 (fr) 2017-03-29 2020-02-05 H. Hoffnabb-La Roche Ag Molécule bispécifique de liaison à l'antigène pour un récepteur de co-stimulation du tnf
CN107058596A (zh) * 2017-06-19 2017-08-18 上海市第十人民医院 一种与恶性胶质瘤诊断相关的标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8547291A (en) * 1990-09-05 1992-03-30 Wistar Institute, The Monoclonal antibodies against tenascin
JPH0643167A (ja) * 1992-04-06 1994-02-18 Amano Pharmaceut Co Ltd 癌マーカーであるテネイシン及びその定量法
NZ288883A (en) * 1994-07-11 1998-12-23 Univ Texas Conjugates comprising coagulation factors
WO1996008513A1 (fr) * 1994-09-16 1996-03-21 The Scripps Research Institute Derives de cytotactine stimulant la connexion neuronale et la croissance des axones et des dendrites, leurs procedes de preparation et d'utilisation
JP3850492B2 (ja) * 1996-08-23 2006-11-29 独立行政法人理化学研究所 テネイシン誘導因子

Also Published As

Publication number Publication date
ITFI990094A0 (it) 1999-04-20
US7109301B1 (en) 2006-09-19
AU779015B2 (en) 2005-01-06
IT1307864B1 (it) 2001-11-19
AU4401500A (en) 2000-11-02
ES2226823T3 (es) 2005-04-01
CA2370666A1 (fr) 2000-10-26
EP1173766B1 (fr) 2004-09-22
DE60014064T2 (de) 2006-02-23
CA2370666C (fr) 2010-06-01
EP1173766A1 (fr) 2002-01-23
JP2002542486A (ja) 2002-12-10
ATE277352T1 (de) 2004-10-15
ITFI990094A1 (it) 2000-10-20
JP4577665B2 (ja) 2010-11-10
WO2000063699A1 (fr) 2000-10-26
DE60014064D1 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
CY1112458T1 (el) Ενα αντισωμα ειδικο για διαλυτο baff για χρηση στην αντιμετωπιση του καρκινου
CY1123400T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NO20020554L (no) Antistoff-molekyler med spesifisitet for human tumornekrosefaktor-alfa, og anvendelse derav
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
AR040748A1 (es) Un metodo y un sistema para posicionar unidades moviles utilizando mediciones de angulo
CR8231A (es) Anticuerpos rg1 y uso de los mismos
CY1109468T1 (el) Χρησεις ανταγωνιστων της il-23. σχετικα αντιδραστηρια
DE602004019812D1 (de) Marker für neuromyelitis optica
CY1110923T1 (el) Συζυγη που περιλαμβανουν ενα αντισωμα ειδικο για την ed-β περιοχη της ινονεκτινης και η χρηση τους για τον εντοπισμο και την αντιμετωπιση ογκων
BR0115124B1 (pt) dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
ECSP10010653A (es) Anticuerpos anti-il-17a/il-17f de reactividad cruzada y métodos de uso de los mismos
CR10273A (es) "anticuerpos anti-5t4 y usos de los mismos"
BRPI9910394B8 (pt) molÉculas de ligaÇço especÍfica para cintigrafia e conjugados contendo as mesmas
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
DK1173766T3 (da) Isoform af tenascin-C som markör for neoplasier
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ATE439441T1 (de) Veränderte, fluoreszierende proteine
WO2004032599A3 (fr) Nouvelles proteines immunogenes de leptospira
CY1106200T1 (el) Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους
WO2001096599A3 (fr) Procedes de determination quantitative de b-fibronectine dans des fluides et des tissus biologiques
EP1252190A4 (fr) Anticorps specifiques des proteines presentant des expansions de polyglutamine
ATE299739T1 (de) Neurokinin b vorläufer aus menschlicher plazenta